We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
DomaniCell Cord Blood Banking Program Launched at Saint Peter's University Hospital
News

DomaniCell Cord Blood Banking Program Launched at Saint Peter's University Hospital

DomaniCell Cord Blood Banking Program Launched at Saint Peter's University Hospital
News

DomaniCell Cord Blood Banking Program Launched at Saint Peter's University Hospital

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "DomaniCell Cord Blood Banking Program Launched at Saint Peter's University Hospital"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

DomaniCell, LLC has announced that Saint Peter's University Hospital has recently partnered with DomaniCell to provide a hospital-based cord blood banking program.

Since its beginnings in 1907, Saint Peter's University Hospital has grown to a 478-bed teaching hospital with a full range of specialized pediatric healthcare services and one of the largest neonatal intensive care units in the country. As a state-designated acute care children's hospital, Saint Peter's offers a full range of specialized pediatric healthcare service with one of the most sophisticated maternity programs and one of the largest, most advanced neonatal intensive care units in the country.

The DomaniCell program involves hospitals partnering with DomaniCell to develop their own cord blood stem cell banking program that is built on DomaniCell infrastructure and technology.

DomaniCell's program is built upon years of clinical and industry experience gained through its parent company, Progenitor Cell Therapy LLC. Progenitor Cell Therapy's management team has over 135 years of combined experience in cell therapy, built five cGMP facilities, and participated in over 50 regulatory filings in the US and Europe.

"We are very excited about the business advantages DomaniCell is offering to its hospital partners though our turnkey solution. By launching a cord blood program with DomaniCell, Saint Peter's University Hospital has demonstrated a commitment to providing the highest quality and most advanced health-related services to its community."

Advertisement